跳至主要内容
临床试验/IRCT201409251155N22
IRCT201409251155N22已完成3 期

Effect of three methods of Naproxen ,Isosorbide Dinitrate and concurrent use of them in prevention of Post- ERCP Pancreatitis

Vice chancellor for research of Guilan University of Medical Sciences0 个研究点目标入组 585 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
585

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • All patients over 18 years who were referred to Razi Hospital of Rasht for ERCP. Exclusion criteria: Acute pancreatitis in the last two weeks; history of chronic pancreatitis; a history of previous sphincterotomy; NSAID or Nitrate usage in a week prior and contraindication for NSAID or Nitrate usage like renal failure; recent Peptic Ulcer disease with recent GI Bleeding; Hypotension and Hypersensitivity to recent Each of the two drugs and lack of satisfaction of participate in this study.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research of Guilan University of Medical Sciences

相似试验